| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/16/2003 | US20030013125 Compound for use in drug development |
| 01/16/2003 | US20030013123 Isolation of trophoblast cells; obtain blood cells, incubate with binding agent, recover cells |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013121 Diagnostic test kit |
| 01/16/2003 | US20030013120 Protein profiling system for use in monitoring preferential gene expression patterns |
| 01/16/2003 | US20030013118 Methods of determining resistance to treatment for hepatitis c virus |
| 01/16/2003 | US20030013116 Multiplex protein interaction determinations using glutathione-GST binding |
| 01/16/2003 | US20030013113 Detection of binding domain in polypeptide; obtain polypeptide, incubate with ligand, expose spectrum analysis, detect binding domain in protein |
| 01/16/2003 | US20030013111 Method and apparatus for solid state molecular analysis |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013107 Alpha 2 integrin: modulators of lymphocyte activation |
| 01/16/2003 | US20030013105 Methods for identifying drugs specific for known molecular targets using model compounds specific for the molecular targets |
| 01/16/2003 | US20030013103 Apparatus and method for detecting and identifying infectious agents |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030013097 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 01/16/2003 | US20030013093 Diagnosis of diabetes and insulin resistance in humans; obtain adipose cells, extract nucleotide sequences, determine gene expression patterns, evaluate for diabetes and insulin resistance |
| 01/16/2003 | US20030013091 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | US20030013088 Fluorescent substances |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013086 Method of analysis of samples by determination of a function of specific brightness |
| 01/16/2003 | US20030013084 Organometallic probe |
| 01/16/2003 | US20030013083 Particle analysis as a detection system for particle-enhanced assays |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013079 Generation of preferential viral particle; obtain cells, transform with expresion vector, culture cell, recover viral particle |
| 01/16/2003 | US20030013078 Expression vector for use in the prevention and treatment of vial infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |
| 01/16/2003 | US20030012953 Non-stoichiometric non- equilibrium material, and the material is a nanostructured material;e.g., boron nitrides, tin oxides, titanium carbides and nickel ferrites |
| 01/16/2003 | US20030012952 Nanotechnology for electrochemical and energy devices |
| 01/16/2003 | US20030012788 Determining activation of various molecules, such as JAK-1, Tyk2, to identify molecules which mediate this interaction by measuring the activity of one or more of the molecules in the pathway to identify agonists and antagonists. |
| 01/16/2003 | US20030012777 Polymer conjugates of proteinases |
| 01/16/2003 | US20030012732 Feeding an ingestible substrate of radiolabeled microbeads and detecting an increase or decrease in ingested substrate as compared to that which has been ingested by a control nematode sample incubated without a candidate nematocide |
| 01/16/2003 | US20030012696 Concentrations of water, carbon dioxide, carbon monoxide, nitrogen oxides, volatile organic comnpounds successively analysed |
| 01/16/2003 | US20030012695 Substrates comprising polynucleotide microarrays |
| 01/16/2003 | US20030012694 System for the analysis of biological liquids |
| 01/16/2003 | US20030012692 Detection of reactions and metabolic changes with fluorscent materials |
| 01/16/2003 | US20030012078 Method for dispersing red and white blood cells |
| 01/16/2003 | US20030011773 Non-invasive measurement of skin bilirubin level |
| 01/16/2003 | US20030011759 Proof testing capstans for reducing shear and fiber coating deformation |
| 01/16/2003 | US20030011387 Determination of chloride corrosion threshold for metals embedded in cementitious material |
| 01/16/2003 | US20030011386 Methods and apparatus for estimating on-line water conductivity of multiphase mixtures |
| 01/16/2003 | US20030011374 Sensor for the monitoring of an NOx catalyst |
| 01/16/2003 | US20030010910 Continuous fiber of single-wall carbon nanotubes |
| 01/16/2003 | US20030010909 Device for delivery of multiple liquid sample streams to a mass spectrometer |
| 01/16/2003 | US20030010711 Blood component separator disk |
| 01/16/2003 | US20030010653 Determined by use of a nonlinear expression which expresses an approximated relationship between the second pump current and the concentration of NOx in the gas under measurement; accuracy even in low concentrations; auto exhaust systems |
| 01/16/2003 | US20030010635 Flow gap gas distribution adapter for an electrochemical gas sensor |
| 01/16/2003 | US20030010633 Method of treating metal analysis sample and device thereof |
| 01/16/2003 | DE20216887U1 Measuring arrangement used for determining organic and inorganic constituents of water in standing or flowing bodies of water comprises light source, collimating optical element, and optical detectors |
| 01/16/2003 | DE10138417C1 Thickness measuring device for concrete or asphalt layers uses transmission coil and relatively spaced reception coils cooperating with metal surfaces below concrete or asphalt layer |
| 01/16/2003 | CA2798555A1 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | CA2519161A1 Sir2 activity |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453068A1 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452878A1 Thermal printhead adjustment |
| 01/16/2003 | CA2452849A1 Method for monitoring and modulating protein folding |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452691A1 Dendritic cell isolation methods |
| 01/16/2003 | CA2452663A1 Method for screening molecules which can bind to the gp120 protein of the immunodeficiency virus |
| 01/16/2003 | CA2452660A1 Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
| 01/16/2003 | CA2452628A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | CA2452578A1 Ephrin and eph receptor mediated immune modulation |
| 01/16/2003 | CA2452392A1 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 01/16/2003 | CA2452366A1 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | CA2452315A1 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2451193A1 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase |
| 01/16/2003 | CA2451092A1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 01/16/2003 | CA2450937A1 Method for separating and/or detecting and/or identifying and/or quantifying prion proteins |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2447728A1 Nanoscale wires and related devices |
| 01/16/2003 | CA2442741A1 Human secreted proteins |
| 01/16/2003 | CA2353120A1 Caged compound cleaving process |
| 01/15/2003 | EP1275965A1 Method for identifying substances which modulate interleukin 4 (IL-4) signaling |
| 01/15/2003 | EP1275964A1 Measuring method for immunochromatographic test strip |
| 01/15/2003 | EP1275963A2 Volume meter testing device |
| 01/15/2003 | EP1275962A1 Method for detecting oxidizing substances or free radicals in saliva and corresponding kit |
| 01/15/2003 | EP1275737A2 Compositions and processes for analyte detection; quantification and amplification |
| 01/15/2003 | EP1275733A2 Assay methods for peptidase modulators |
| 01/15/2003 | EP1275732A1 Electrochemical test sensor with an underfill detection system |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275655A1 Silicon-containing linkers for nucleic acid mass markers |
| 01/15/2003 | EP1275635A1 Calcium receptor-active compounds |
| 01/15/2003 | EP1275410A2 A blood filter |
| 01/15/2003 | EP1275398A1 Diagnostics and remedies for rheumatoid arthritis |
| 01/15/2003 | EP1275006A2 Proteomic analysis using activity-based probe libraries |
| 01/15/2003 | EP1275004A2 Mass labels |
| 01/15/2003 | EP1275003A2 Diagnostic assay for endometriosis |
| 01/15/2003 | EP1275001A2 Diagnostic device with multiple independent flow paths |
| 01/15/2003 | EP1275000A1 Detection of erythropoietin and erythtropoietin receptor |
| 01/15/2003 | EP1274999A1 Method and test strip of detecting oxidizing adulterant in urine |
| 01/15/2003 | EP1274997A2 Comparative phenotype analysis for assessment of biologically active compounds |
| 01/15/2003 | EP1274996A1 Proteomic analysis by parallel mass spectrometry |
| 01/15/2003 | EP1274995A1 Improved interface patch clamping |